FDA Adverse Event Malfunction Summary report: N

ADVIA CENTAUR

MDR report key: 24889473 · Received April 15, 2026

Report

Report Number
1219913-2026-00079
Event Type
Malfunction
Date Received
April 15, 2026
Date of Event
April 10, 2026
Report Date
May 15, 2026
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
SEI
UDI-DI
000630414591407
PMA / PMN Number
P100039
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A CUSTOMER FROM OUTSIDE THE UNITED STATES REPORTED OBSERVATION OF FALSE REACTIVE (POSITIVE) ADVIA CENTAUR ANTI-HBS2 (AHBS2) RESULT FOR ONE PATIENT SAMPLE WHEN USING LOT 174 WHICH WAS DISCORDANT RELATIVE TO REPEAT TESTING USING DIFFERENT REAGENT LOT 176. SIEMENS IS EVALUATING THE EVENT.

Description of Event or Problem · 0

THE CUSTOMER REPORTS OBSERVATION OF FALSE REACTIVE (POSITIVE) ADVIA CENTAUR ANTI-HBS2 (AHBS2) RESULT FOR ONE PATIENT SAMPLE WHEN USING LOT 174 WHICH WAS DISCORDANT RELATIVE TO REPEAT TESTING USING DIFFERENT REAGENT LOT 176. THE INITIAL REACTIVE RESULT WAS NOT REPORTED TO THE PHYSICIAN(S). THE SAMPLE WAS REPROCESSED ON THE ORIGINAL ANALYZER WITH SAME REAGENT LOT, AGAIN YIELDING A REACTIVE RESULT. THE SAME SAMPLE WAS THEN REPROCESSED TWICE ON AN ALTERNATE ADVIA CENTAUR XP ANALYZER USING ANOTHER REAGENT LOT, AND BOTH RUNS PRODUCED NON-REACTIVE RESULTS. THE NONREACTIVE RESULTS WERE CONSIDERED CORRECT, AS THEY WERE IN AGREEMENT WITH THE PATIENT'S CLINICAL PICTURE. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSE REACTIVE AHBS2 RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
158827 ADVIA CENTAUR ADVIA CENTAUR ANTI-HEPATITIS B SURFACE ANTIGEN 2 (AHBS2) SEI SIEMENS HEALTHCARE DIAGNOSTICS INC. N/A 41082174 000630414591407

Patients

Seq Age Sex Outcome Treatment
1 61 YR Female